SCHEMBL5997919

SCHEMBL5997919

CC(C)CN(c1cccc(CC(C)CNC(=O)[C@H](NC(=O)C2CCCN2C(=O)OCc2ccccc2)C(C)(C)C)c1O)S(=O)(=O)c1ccc2c(c1)OCO2

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.46
ALDH1A1 P00352 2/20 0.46
CTRB1 P17538 1/20 0.40
CYP3A4 P08684 1/20 0.40
MAPT P10636 1/20 0.40
CYP2C9 P11712 1/20 0.40
RAB9A P51151 1/20 0.40
KMT2A Q03164 2/20 0.37
GFER P55789 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
TP53 P04637 1/20 0.36
CTSK P43235 2/20 0.36
CTSL P07711 1/20 0.36
BMP1 P13497 1/20 0.35
HSD17B10 Q99714 1/20 0.35
USP2 O75604 1/20 0.35
MEN1 O00255 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.34
KDM4E B2RXH2 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5688727 0.87 BMP1 (0.39) TSHRALDH1A1MAPTRAB9ASMN1; SMN2
SCHEMBL5492810 0.80 TSHR (0.49) TSHRALDH1A1CTRB1CYP3A4MAPT
SCHEMBL5691126 0.77 KEAP1 (0.39) TSHRALDH1A1MAPTKMT2ANPSR1
SCHEMBL5928586 0.74 MMP2 (0.40) TSHRALDH1A1MAPTKMT2ANPSR1
SCHEMBL7955245 0.73 KEAP1 (0.40) TSHRALDH1A1MAPTKMT2ANPSR1
SCHEMBL5689205 0.73 KEAP1 (0.40) TSHRALDH1A1MAPTKMT2ANPSR1
SCHEMBL5928160 0.72 KEAP1 (0.38) TSHRALDH1A1MAPTKMT2ASMN1; SMN2
SCHEMBL7953042 0.72 KEAP1 (0.39) TSHRALDH1A1MAPTKMT2ANPSR1
SCHEMBL7959894 0.72 KEAP1 (0.38) TSHRALDH1A1MAPTKMT2ANPSR1
Hydrochloric Acid SCHEMBL5506705 0.72 KEAP1 (0.38) TSHRALDH1A1MAPTRAB9AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7141594-B2 inhibitors of HIV protease for treating AIDS G. D. SEARLE & CO. (US) 2006-11-28 US disclosed
US-20040198989-A1 Heterocyclecarbonyl amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors G.D. SEARLE & CO. (US) 2004-10-07 US disclosed
US-6673822-B2 Heterocyclecarbonyl amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors G.D. SEARLE & CO. 2004-01-06 US disclosed
US-20030130202-A1 Heterocyclecarbonyl amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors G.D. SEARLE & CO. 2003-07-10 US disclosed
EP-0815124-B1 HETEROCYCLECARBONYL AMINO ACID HYDROXYETHYLAMINO SULFONAMIDE RETROVIRAL PROTEASE INHIBITORS SEARLE & CO (US) 2002-12-04 EP disclosed
US-6214861-B1 ENZYME INHIBITOR; VIRICIDES G.D. SEARLE & CO. 2001-04-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040198989-A1 Heterocyclecarbonyl amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors DNPEP, PREP, ANPEP TSHR 4778/4885ALDH1A1 3625/4885CTRB1 138/4885
US-20030130202-A1 Heterocyclecarbonyl amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors DNPEP, PREP, ANPEP TSHR 4778/4885ALDH1A1 3625/4885CTRB1 138/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.